Silencing miR-106b improves palmitic acid-induced mitochondrial dysfunction and insulin resistance in skeletal myocytes

Zhang,Ying; Zhao,Ya‑Ping; Gao,Yuan‑Fu; Fan,Zhong‑Min; Liu,Meng‑Yuan; Cai,Xiao‑Yi; Xia,Zheng‑Kun; Gao,Chun‑Lin

doi:10.3892/mmr.2014.3124

Silencing miR-106b improves palmitic acid-induced mitochondrial dysfunction and insulin resistance in skeletal myocytes

Authors:
- Ying Zhang
- Ya‑Ping Zhao
- Yuan‑Fu Gao
- Zhong‑Min Fan
- Meng‑Yuan Liu
- Xiao‑Yi Cai
- Zheng‑Kun Xia
- Chun‑Lin Gao
View Affiliations

Affiliations: Department of Pediatrics, Jinling Hospital, Nanjing University, School of Medicine, Nanjing, Jiangsu 210002, P.R. China, Department of Pediatrics, The 82nd Hospital of the People's Liberation Army, Huai'an, Jiangsu 223001, P.R. China
Published online on: December 22, 2014 https://doi.org/10.3892/mmr.2014.3124
Pages: 3834-3841

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

MicroRNA‑106b (miR‑106b) is reported to correlate closely with skeletal muscle insulin resistance. In the current study the effect of miR‑106b on palmitic acid (PA)‑induced mitochondrial dysfunction and insulin resistance was investigated in C2C12 myotubes via the silencing of miR‑106b. MiR‑106b expression was increased under PA treatment, while miR‑106b loss of function improved insulin sensitivity by upregulating its target mitofusin‑2 (Mfn2) in C2C12 myocytes. Furthermore, miR‑106b loss of function partly improved mitochondrial morphological lesions and increased the levels of mitochondial DNA and intracellular adenosine triphosphate that had been impaired by PA exposure in C2C12 myocytes. MiR‑106b loss of function attenuated the levels of intracellular reactive oxygen species (ROS), and upregulated the expression levels of the estrogen‑related receptor (ERR)‑α/peroxisome proliferative activated receptor γ coactivator (PGC)‑1α/Mfn2 axis under PA exposure. In addition, miR‑106b negatively regulated skeletal muscle mitochondrial function and insulin sensitivity under PA‑induced insulin resistance by targeting Mfn2, which may be associated with reduced ROS and upregulation of the ERR‑α/PGC‑1α/Mfn2 axis.

View Figures

View References

1	Petersen KF and Shulman GI: Etiology of insulin resistance. Am J Med. 119:S10–16. 2006. View Article : Google Scholar : PubMed/NCBI
2	Hirabara SM, Silveira LR, Abdulkader F, Carvalho CR, Procopio J and Curi R: Time-dependent effects of fatty acids on skeletal muscle metabolism. J Cell Physiol. 210:7–15. 2007. View Article : Google Scholar
3	McGarry JD: Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes. 51:7–18. 2002. View Article : Google Scholar : PubMed/NCBI
4	Silveira LR, Fiamoncini J, Hirabara SM, et al: Updating the effects of fatty acids on skeletal muscle. J Cell Physiol. 217:1–12. 2008. View Article : Google Scholar : PubMed/NCBI
5	Brehm A, Krssak M, Schmid AI, Nowotny P, Waldhausl W and Roden M: Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle. Diabetes. 55:136–140. 2006. View Article : Google Scholar
6	Chanseaume E, Malpuech-Brugére C, Patrac V, et al: Diets high in sugar, fat, and energy induce muscle type-specific adaptations in mitochondrial functions in rats. J Nutr. 136:2194–2200. 2006.PubMed/NCBI
7	Schrauwen P, Schrauwen-Hinderling V, Hoeks J and Hesselink MK: Mitochondrial dysfunction and lipotoxicity. Biochim Biophys Acta. 1801:266–271. 2010. View Article : Google Scholar
8	Schrauwen-Hinderling VB, Hesselink MK, Schrauwen P and Kooi ME: Intramyocellular lipid content in human skeletal muscle. Obesity (Silver Spring). 14:357–367. 2006. View Article : Google Scholar
9	Koves TR, Ussher JR, Noland RC, et al: Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 7:45–56. 2008. View Article : Google Scholar : PubMed/NCBI
10	Guo H, Ingolia NT, Weissman JS and Bartel DP: Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 466:835–840. 2010. View Article : Google Scholar : PubMed/NCBI
11	Ferland-McCollough D, Ozanne SE, Siddle K, Willis AE and Bushell M: The involvement of microRNAs in Type 2 diabetes. Biochemical Society Transactions. 38:1565–1570. 2010. View Article : Google Scholar
12	Poy MN, Spranger M and Stoffel M: microRNAs and the regulation of glucose and lipid metabolism. Diabetes Obes Metab. 9(Suppl 2): 67–73. 2007. View Article : Google Scholar : PubMed/NCBI
13	Gallagher IJ, Scheele C, Keller P, et al: Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes. Genome Med. 2:92010. View Article : Google Scholar : PubMed/NCBI
14	Chen GQ, Lian WJ, Wang GM, Wang S, Yang YQ and Zhao ZW: Altered microRNA expression in skeletal muscle results from high-fat diet-induced insulin resistance in mice. Mol Med Report. 5:1362–1368. 2012.
15	Zhang Y, Yang L, Gao YF, et al: MicroRNA-106b induces mitochondrial dysfunction and insulin resistance in C2C12 myotubes by targeting mitofusin-2. Mol Cell Endocrinol. 381:230–240. 2013. View Article : Google Scholar : PubMed/NCBI
16	Shi CM, Wang YM, Zhang CM, et al: Knockdown of NYGGF4 (PID1) rescues insulin resistance and mitochondrial dysfunction induced by FCCP in 3T3-L1 adipocytes. Mitochondrion. 12:600–606. 2012. View Article : Google Scholar : PubMed/NCBI
17	Houstis N, Rosen ED and Lander ES: Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature. 440:944–948. 2006. View Article : Google Scholar : PubMed/NCBI
18	Soriano FX, Liesa M, Bach D, Chan DC, Palacin M and Zorzano A: Evidence for a mitochondrial regulatory pathway defined by peroxisome proliferator-activated receptor-gamma coactivator-1 alpha, estrogen-related receptor-alpha, and mitofusin-2. Diabetes. 55:1783–1791. 2006. View Article : Google Scholar : PubMed/NCBI
19	Zorzano A: Regulation of mitofusin-2 expression in skeletal muscle. Appl Physiol Nutr Metab. 34:433–439. 2009. View Article : Google Scholar : PubMed/NCBI
20	Russell AP, Gastaldi G, Bobbioni-Harsch E, et al: Lipid peroxidation in skeletal muscle of obese as compared to endurance-trained humans: a case of good vs. bad lipids? FEBS Lett. 551:104–106. 2003. View Article : Google Scholar : PubMed/NCBI
21	Schrauwen P, Mensink M, Schaart G, et al: Reduced skeletal muscle uncoupling protein-3 content in prediabetic subjects and type 2 diabetic patients: restoration by rosiglitazone treatment. J Clin Endocrinol Metab. 91:1520–1525. 2006. View Article : Google Scholar
22	Jheng HF, Tsai PJ, Guo SM, et al: Mitochondrial fission contributes to mitochondrial dysfunction and insulin resistance in skeletal muscle. Mol Cell Biol. 32:309–319. 2012. View Article : Google Scholar :
23	Liesa M, Palacín M and Zorzano A: Mitochondrial dynamics in mammalian health and disease. Physiol Rev. 89:799–845. 2009. View Article : Google Scholar : PubMed/NCBI
24	Bach D, Naon D, Pich S, et al: Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6. Diabetes. 54:2685–2693. 2005. View Article : Google Scholar : PubMed/NCBI
25	Mingrone G, Manco M, Calvani M, Castagneto M, Naon D and Zorzano A: Could the low level of expression of the gene encoding skeletal muscle mitofusin-2 account for the metabolic inflexibility of obesity? Diabetologia. 48:2108–2114. 2005. View Article : Google Scholar : PubMed/NCBI
26	Sebastian D, Hernandez-Alvarez MI, Segales J, et al: Mitofusin-2 (Mfn2) links mitochondrial and endoplasmic reticulum function with insulin signaling and is essential for normal glucose homeostasis. Proc Natl Acad Sci USA. 109:5523–5528. 2012. View Article : Google Scholar
27	Gao X, Zhao XL, Zhu YH, et al: Tetramethylpyrazine protects palmitate-induced oxidative damage and mitochondrial dysfunction in C2C12 myotubes. Life Sci. 88:803–809. 2011. View Article : Google Scholar : PubMed/NCBI
28	Vielhaber S, Debska-Vielhaber G, Peeva V, et al: Mitofusin-2 mutations affect mitochondrial function by mitochondrial DNA depletion. Acta Neuropathol. 125:245–256. 2013. View Article : Google Scholar
29	Lally JS, Herbst EA, Matravadia S, et al: Over-expressing mitofusin-2 in healthy mature mammalian skeletal muscle does not alter mitochondrial bioenergetics. PLoS One. 8:e556602013. View Article : Google Scholar : PubMed/NCBI
30	Zorzano A, Hernández-Alvarez MI, Palacin M and Mingrone G: Alterations in the mitochondrial regulatory pathways constituted by the nuclear co-factors PGC-1alpha or PGC-1beta and mitofusin 2 in skeletal muscle in type 2 diabetes. Biochim Biophys Acta. 1797:1028–1033. 2010. View Article : Google Scholar : PubMed/NCBI